| Lastest Insider Transactions Of SAB Biotherapeutics, Inc. ( SABS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| SABS | SAB Biotherapeutics, Inc. | Moin Andrew | Directior | 2025-09-29 | Option Exercise | 1,740,000 | 1.75 | 3,045,000 | 2025-10-01 16:35:03 |
| SABS | SAB Biotherapeutics, Inc. | Sessa Capital (Master), L.P. | Directior | 2025-09-29 | Option Exercise | 1,740,000 | 1.75 | 3,045,000 | 2025-10-01 16:06:19 |
| SABS | SAB Biotherapeutics, Inc. | Sullivan Eddie Joe | Chief Executive Officer | 2023-12-07 | Buy | 1,740 | 0.88 | 1,531 | 2023-12-08 08:00:05 |
| SABS | SAB Biotherapeutics, Inc. | King Michael | CHIEF FINANCIAL OFFICER | 2023-11-30 | Buy | 5,000 | 0.90 | 4,500 | 2023-11-30 17:00:07 |
| SABS | SAB Biotherapeutics, Inc. | Reich Samuel J | Executive Chairman | 2023-11-29 | Buy | 11,000 | 0.89 | 9,842 | 2023-11-30 08:00:04 |
| SABS | SAB Biotherapeutics, Inc. | Sessa Capital (Master), L.P. | Directior | 2023-11-24 | Option Exercise | 4,584,571 | 0.00 | 0 | 2023-11-28 16:05:50 |
| SABS | SAB Biotherapeutics, Inc. | Moin Andrew | Directior | 2023-11-24 | Option Exercise | 4,584,571 | 0.00 | 0 | 2023-11-28 16:05:14 |
| SABS | SAB Biotherapeutics, Inc. | Ellias Helen K. | Directior | 2023-11-24 | Option Exercise | 2,857,142 | 0.00 | 0 | 2023-11-28 16:05:09 |
